Locked price vs escalating price
SnagRx vs IVIM Health: Which Price Survives Titration? (2026)
SnagRx costs $1,188 a year against $2,013 for IVIM Health. Full 2026 comparison of price, medication class and included support.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.5 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
SnagRx and IVIM Health sit at ranks 15 and 21 in our weight loss listing, which makes them close enough to be a genuine decision rather than an obvious one.
SnagRx charges the same amount at 0.25 mg and at the top of the titration ladder. IVIM Health does not — its price steps up from $99 to $174 — and that is the difference the first-month headline hides.
Each program is read on its own published terms first, then against the other on the four things that decide satisfaction: price, predictability, formulary and access to a clinician. Every figure traces back to the provider's own published material, and the missing ones stay missing.
The short answer
- Lowest 12-month cost
- SnagRx — $828 against $2,013 at IVIM Health, on each provider's own best published pricing.
- Most predictable bill
- SnagRx — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- SnagRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Widest medication choice
- SnagRx — compounded semaglutide and compounded tirzepatide.
Side-by-side comparison
Scan the pricing rows first, then the medication row. Those two settle most of these decisions between them.
| SnagRx | IVIM Health | |
|---|---|---|
| Advertised price | Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan | $99 first month, then $174/mo |
| Rate after promotions | $99/mo | $174/mo |
| Pricing structure | Flat rate at every dose | Membership fee plus the cost of medication |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| Support model | No coaching program stated | Provider check-ins included |
| Shipping | Free next-day UPS or FedEx in temperature-controlled packaging | Home delivery |
| Price transparency | Published upfront | Published upfront |
| Tirzepatide | $149/mo | Not published |
| Patient reviews | 9,860 | 36,958 |
| eRxDoctor score | 7.5/10 | 7.0/10 |
Cost over a full course of treatment
Both providers lead with a number designed to get you through the intake. The totals below are the honest version, built from the rates each provider publishes.
| SnagRx | IVIM Health | |
|---|---|---|
| First month | $99 | $99 |
| Months 2 onward | $99/mo | $174/mo |
| 6-month total | $594 | $969 |
| 12-month total | $1,188 | $2,013 |
| Best published plan | 12-month semaglutide plan at $69/mo ($828 a year) — $828/yr | No multi-month discount published |
The twelve-month spread is $1,185. That is the number to hold IVIM Health against: it has to justify roughly $99 extra every month.
Price escalation to plan for: IVIM Health moves from $99 to $174, a 76% increase. Set a calendar reminder for the month it changes.
What happens to the price as your dose goes up
Semaglutide and tirzepatide are titrated upward over the first months of treatment. Some providers price per milligram in all but name, so the invoice climbs alongside the dose; others hold one rate the whole way.
SnagRx is in the second group: the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly. IVIM Health is in the first — the GLP-1 ID protocol's 40% faster claim is the platform's own, not an independent finding — which means the number you compared at signup is not the number you will be paying at month four.
The fix is one question at intake: what do I pay at maintenance dose? Everything else about pricing follows from that answer.
Inside the SnagRx program
SnagRx positions itself on the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly. SnagRx offers compounded semaglutide from $69/month and tirzepatide from $119/month, with the rate locked flat at every dose, named US 503A pharmacies and next-day shipping.
Getting started means 5-minute intake, clinician review typically within 5 hours and always within 24, after which free next-day UPS or FedEx in temperature-controlled packaging. Pricing runs on a flat rate at every dose basis, published upfront.
Ongoing care is 1:1 nursing staff plus a secure patient portal for refills and dose changes, and the medication list runs to compounded semaglutide and compounded tirzepatide.
SnagRx pros
- Clinician review typically within 5 hours; next-day temperature-controlled shipping
- Full refund if the prescription is declined, plus a 6-month weight-loss guarantee (terms apply)
- Names its four US 503A partner pharmacies and its clinician network (OpenLoop Health)
- States LegitScript certification, which patients can verify independently
SnagRx cons
- Heavy urgency marketing, including a countdown timer on the pricing page
- No coaching or nutrition programming of any kind
- Compounded medication only, no branded Ozempic, Wegovy, Mounjaro, or Zepbound
Against IVIM Health specifically, the trade you are making: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
IVIM Health: what you are buying
Limited Offer: Free Month Membership – Use Code GIFT75
The process is free consult, then clinician review, then home delivery. On money, expect membership fee plus the cost of medication — published upfront.
Behind the prescription sits no-obligation free consultation valued at $75. Available medication: compounded semaglutide.
IVIM Health pros
- Competitive ongoing pricing at $174/month after a $99 first month
- Proprietary GLP-1 ID protocol claiming up to 40% faster weight loss
- Free month membership with code GIFT75
- No-obligation free consultation ($75 value) for new patients
IVIM Health cons
- Compounded medication only, no branded Ozempic or Wegovy
- The 40% faster claim is a proprietary protocol claim, not an independent clinical finding
- Price rises from $99 first month to $174/month ongoing
Set beside SnagRx, the thing to weigh: the GLP-1 ID protocol's 40% faster claim is the platform's own, not an independent finding.
Which one fits which patient
Choose SnagRx if:
- you want the price you sign up at to survive titration
- the monthly rate is the constraint — $99/mo against $174/mo
- you are willing to commit for a term in exchange for a lower effective rate (12-month semaglutide plan at $69/mo ($828 a year))
- you want tirzepatide available without changing provider later
Choose IVIM Health if:
- what it leads on is worth paying for in your case: 4.9 stars on both Google and Trustpilot, which is rare dual third-party verification
- the level of clinical contact suits you: no-obligation free consultation valued at $75
- you want to start on their timeline: free consult, then clinician review
- delivery works the way you want it to: home delivery
What each one gives up
On price. SnagRx is the cheaper program at $99/mo against $174/mo. What SnagRx gives up for that is the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149; what IVIM Health charges for is 4.9 stars on both Google and Trustpilot, which is rare dual third-party verification.
On access. SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24 and free next-day UPS or FedEx in temperature-controlled packaging; IVIM Health advertises free consult, then clinician review and home delivery. Coverage differs too — 48 states against not published — which decides the question before price does if you are in a restricted state.
On predictability. The pricing structures differ (flat rate at every dose versus membership fee plus the cost of medication), and structure, not headline rate, determines the twelve-month bill.
On clinical contact. The support models differ — 1:1 nursing staff plus a secure patient portal for refills and dose changes against no-obligation free consultation valued at $75 — and that difference is felt in week two, not week one.
The clinical evidence, separated from the marketing
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
In SURMOUNT-4, stopping tirzepatide after a lead-in period produced significant weight regain, where staying on it did not, per JAMA, SURMOUNT-4.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
SnagRx vs IVIM Health: common questions
Is SnagRx cheaper than IVIM Health?
Yes, on the ongoing rate. SnagRx runs $99/mo once promotional pricing ends, against $174/mo at IVIM Health — a difference of 76%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Can I switch from SnagRx to IVIM Health later?
Nothing stops you. The friction is administrative rather than clinical: a new intake, a new prescriber, and a delivery gap if you time it badly. Move while you still have two weeks of medication in the fridge, and read the cancellation terms on any prepaid plan before you do.
Is SnagRx or IVIM Health better for a first GLP-1 prescription?
If this is your first GLP-1, the question is who answers when nausea arrives on day nine. IVIM Health publishes no-obligation free consultation valued at $75, which is the more useful thing to buy at the start.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
Are SnagRx and IVIM Health legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. SnagRx operates on flat rate at every dose with pricing published upfront, IVIM Health on membership fee plus the cost of medication, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
The verdict
SnagRx is the cheaper year by $1,185, and for a straightforward course of treatment that settles it.
Where IVIM Health justifies itself is 4.9 stars on both Google and Trustpilot, which is rare dual third-party verification. Where it does not is anywhere the extra spend buys features you will never open.
Whichever way you go, the medication is the same class of drug and the clinical questions belong to a clinician. What you are choosing here is a billing model and a support structure.
Keep comparing
- Hers vs SnagRxBrand-name vs compounded
- Shed vs SnagRxPublished price vs quote-only
- IVIM Health vs Mochi HealthBudget vs premium
- Novi vs IVIM HealthTirzepatide access
- TMates vs Start WillowLocked price vs escalating price
- TMates vs He & She MDLocked price vs escalating price
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by SnagRx or IVIM Health, and does not sell treatment. Read our ranking methodology.